APYX vs MKC · rev $48.1M vs P/E 8.4, $13.56B cap
Apyx Medical Inc (APYX) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
MKC does not have a complete income-statement cache yet.
APYX currently screens at market cap $179.6M. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the APYX and MKC stock pages for the full models.
Not investment advice.